Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Issues in transfusion therapy in the patient with malignancy

R C Friedberg1

  • 1Department of Pathology, University of Alabama at Birmingham.

Hematology/Oncology Clinics of North America
|December 1, 1994
PubMed
Summary

Transfusion medicine optimizes blood product support for cancer patients, improving survival but requiring careful management of potential long-term complications. Understanding transfusion benefits and risks is crucial for hematology/oncology practitioners.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Proteinase expression during differentiation of human osteoclasts in vitro.

Journal of cellular biochemistry·2000
Same author

Removal of vancomycin during plasmapheresis.

The Annals of pharmacotherapy·1997
Same author

Benefits of platelet crossmatching: a case in point.

CAP today·1997
Same author

Yield of laboratory tests for case-finding in the ambulatory general medical examination.

The American journal of medicine·1997
Same author

Microbiology testing and the pediatrician's office.

The Pediatric infectious disease journal·1997
Same author

Automating clinical practice guidelines: a corporate-academic partnership.

Clinical laboratory management review : official publication of the Clinical Laboratory Management Association·1996

Area of Science:

  • Transfusion Medicine
  • Oncology
  • Hematology

Background:

  • Transfusion medicine has advanced significantly, paralleling therapeutic successes across medical fields.
  • Optimizing blood product support is vital for minimizing complications in patients undergoing treatment.
  • The critical role of transfusion therapy is amplified by improved regimens enhancing survival in malignancy patients.

Purpose of the Study:

  • To highlight the increasing importance of transfusion therapy in oncology.
  • To emphasize the need for understanding both short-term benefits and long-term sequelae of transfusions in cancer care.
  • To underscore the necessity for practitioners to grasp the full spectrum of transfusion therapy implications.

Main Methods:

  • Review of current practices in blood product collection, selection, modification, and creation.

Related Experiment Videos

  • Analysis of the interplay between short-term therapeutic success and long-term transfusion outcomes in oncology.
  • Examination of clinical intentions behind blood product administration.

    • Main Results:

    • Transfusion therapy is indispensable for augmenting survival in patients with malignancy.
    • Recognition of long-term transfusion complications in oncology is contingent upon achieving short-term treatment success.
    • Blood products are meticulously prepared for specific clinical objectives.

    Conclusions:

    • Practitioners in hematology/oncology must possess a comprehensive understanding of transfusion therapy.
    • There is a growing need to focus on the long-term implications and potential complications associated with blood product transfusions.
    • Effective transfusion management balances immediate clinical needs with the anticipation of future health outcomes.